(Q42548051)

2 November 2017

Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease (English)

1 reference

2 November 2017

0 references

1 reference

Molina JA

1

1 reference

2 November 2017

Jiménez-Jiménez FJ

2

1 reference

2 November 2017

Gomez P

3

1 reference

2 November 2017

Vargas C

4

1 reference

2 November 2017

Navarro JA

5

1 reference

2 November 2017

Ortí-Pareja M

6

1 reference

2 November 2017

Gasalla T

7

1 reference

2 November 2017

Benito-León J

8

1 reference

2 November 2017

Bermejo F

9

1 reference

2 November 2017

Arenas J

10

1 reference

2 November 2017

1 September 1997

1 reference

Journal of the Neurological Sciences

2 November 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 November 2017

150

1 reference

2 November 2017

2

1 reference

2 November 2017

123-127

1 reference

Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Free and conjugated amino acids in human CSF: influence of age and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Cerebrospinal fluid amino compounds in Parkinson's disease. Alterations due to carbidopa/levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900069-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(97)00069-5

1 reference

2 November 2017

1 reference